Melatonin and Oxidative Stress in the Diabetic State: Clinical Implications and Potential Therapeutic Applications

Area of Science:

• Chronobiology
• Metabolic disease research
• Endocrinology

Background:

• Circadian rhythms regulate essential biological functions, including metabolism.
• Disruption of circadian rhythms is linked to metabolic diseases, particularly type 2 diabetes mellitus (T2DM).
• Melatonin, a pineal hormone, synchronizes circadian rhythms and influences metabolic processes.

Purpose of the Study:

• To explore the role of melatonin in T2DM pathogenesis.
• To investigate the connection between melatonin signaling and metabolic regulation.
• To assess melatonin's potential protective effects against oxidative stress in pancreatic beta-cells.

Main Methods:

• Review of existing evidence on circadian rhythms, melatonin, and T2DM.
• Analysis of genetic association studies linking MT2 receptor polymorphisms to T2DM risk.
• Examination of melatonin's impact on insulin, glucose, lipid metabolism, and antioxidant capacity.

Main Results:

• Disturbances in melatonin production correlate with impaired metabolic functions and reduced antioxidant capacity.
• Genetic variations in the MT2 receptor are associated with an increased risk of developing T2DM.
• Melatonin influences insulin secretion and offers protection against reactive oxygen species (ROS).

Conclusions:

• Endogenous and exogenous melatonin may play a significant role in managing T2DM and related metabolic disorders.
• Melatonin's protective effects extend to pancreatic beta-cells, which are vulnerable to oxidative stress.
• Targeting melatonin pathways could be a therapeutic strategy for T2DM prevention and treatment.